Phase II trial of single agent bortezomib (VELCADE (R)) in patients with previously untreated multiple myeloma (MM) Meeting Abstract
| Authors: | Richardson, P. G.; Chanan-Khan, A.; Schlossman, R. L.; Munshi, N. C.; Wen, P.; Briemberg, H.; Kuter, D.; Oaklander, A. L.; Lonial, S.; Hassoun, H.; Doss, D.; Colson, K.; McKenney, M.; Hande, K.; Koryzna, A.; Stoklas, B.; Lunde, L.; Gorelik, S.; McAlister, C.; Freeman, A.; Warren, D.; Collins, D.; Esseltine, D.; Amato, A.; Anderson, K. C. |
| Abstract Title: | Phase II trial of single agent bortezomib (VELCADE (R)) in patients with previously untreated multiple myeloma (MM) |
| Meeting Title: | 46th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 104 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2004 Dec 4-7 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2004-11-16 |
| Start Page: | 100A |
| Language: | English |
| ACCESSION: | WOS:000225127500338 |
| PROVIDER: | wos |
| PUBMED: | 15562524 |
| DOI: | 10.1182/blood.V104.11.336.336 |
| Notes: | Meeting Abstract: 336 -- 46th Annual Meeting of the American-Society-of-Hematology -- DEC 04-07, 2004 -- San Diego, CA -- 1 -- Source: Wos |
